We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

176 hedge funds and large institutions have $2.96B invested in Aerie Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 75 increasing their positions, 45 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 45

66% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.8M

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

1% more funds holding

Funds holding: 175 → 176 (+1)

0% more capital invested

Capital invested by funds: $2.94B → $2.96B (+$11.6M)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
176
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
4.02%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
26
Increased
75
Reduced
45
Closed
25
Calls
$26.2M
Puts
$15.8M
Net Calls
+$10.4M
Net Calls Change
+$24.3M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$88.8M
2
DM
Deerfield Management
New York
+$67.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.8M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$28.1M
5
NHAS
Novo Holdings A/S
Denmark
+$18.1M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$42.7M
2
PHS
PFM Health Sciences
California
-$29.7M
3
PC
PointState Capital
New York
-$19M
4
HM
HealthCor Management
New York
-$18.1M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
51
Kornitzer Capital Management
Kansas
$10.1M +$10.6M +164,475 New
NCGI
52
Next Century Growth Investors
Minnesota
$9M +$9.4M +146,297 New
DCM
53
DAFNA Capital Management
California
$8.17M +$64.3K +1,000 +0.8%
PC
54
Polar Capital
United Kingdom
$7.69M +$3.21M +50,000 +67%
TCIM
55
TIAA CREF Investment Management
New York
$7.62M +$2.51M +39,014 +46%
EP
56
Eversept Partners
New York
$7.43M -$6.83M -106,191 -47%
Prudential Financial
57
Prudential Financial
New Jersey
$6.9M +$4.14M +64,360 +135%
CWG
58
C WorldWide Group
Denmark
$6.66M -$165K -2,572 -2%
Goldman Sachs
59
Goldman Sachs
New York
$6.58M +$681K +10,586 +11%
UBS AM
60
UBS AM
Illinois
$6.47M +$356K +5,536 +6%
Deutsche Bank
61
Deutsche Bank
Germany
$5.99M -$6.68M -103,871 -52%
Thrivent Financial for Lutherans
62
Thrivent Financial for Lutherans
Minnesota
$5.98M -$753K -11,714 -11%
IBT
63
International Biotechnology Trust
United Kingdom
$5.91M +$7.1M +110,400 +747%
Citigroup
64
Citigroup
New York
$5.89M +$2.1M +32,605 +52%
PVAM
65
Pacific View Asset Management
California
$5.46M +$1.29M +20,131 +29%
Stifel Financial
66
Stifel Financial
Missouri
$5.15M +$361K +5,615 +7%
TAM
67
Tocqueville Asset Management
New York
$4.98M -$209K -3,245 -4%
Macquarie Group
68
Macquarie Group
Australia
$4.96M +$427K +6,641 +9%
AA
69
ALPS Advisors
Colorado
$4.93M +$1.48M +23,058 +40%
MAP
70
Moody Aldrich Partners
Massachusetts
$4.71M +$764K +11,882 +18%
American Century Companies
71
American Century Companies
Missouri
$4.55M +$122K +1,900 +3%
ACM
72
Asymmetry Capital Management
California
$4.49M +$1.49M +23,214 +47%
TA
73
Teachers Advisors
New York
$4.37M +$49.6K +772 +1%
TRSOTSOK
74
Teachers Retirement System of the State of Kentucky
Kentucky
$4.34M +$317K +4,929 +8%
PPA
75
Parametric Portfolio Associates
Washington
$4.25M -$745K -11,586 -14%
1 2
3
4 5

AERI Hedge Fund Activity: Q3 2018 in Review

176 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2018, worth a combined $2.96B — up 0.39% from $2.94B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new AERI positions and 25 closed out — a net gain of 1 holder — while 75 added to existing stakes and 45 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $88.8M. The largest seller was OrbiMed, cutting an estimated $42.7M.

  • 176 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2018, up from 175 in Q2 2018.
  • Funds reported $2.96B of Aerie Pharmaceuticals stock for Q3 2018, up 0.39% quarter-over-quarter.
  • 26 funds opened new Aerie Pharmaceuticals positions in Q3 2018 and 25 closed out, a net change of +1 holder.
  • The largest Aerie Pharmaceuticals buyer in Q3 2018 was Citadel Advisors, an estimated $88.8M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2018 was OrbiMed, an estimated $42.7M sold.

Based on aggregated 13F filings for Q3 2018.